Patent details

Basic Information

Publication number:

EP2240495

PCT Application Number:

PCT/US/2009/031199

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097071286

PCT Publication Number:

WO/2009/099741

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NEMORUBICIN METABOLITE AND ANALOG REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS

French Title of Invention:

MÉTABOLITE DE NÉMORUBICINE ET RÉACTIFS ANALOGUES, CONJUGUÉS ANTICORPS-MÉDICAMENT ET PROCÉDÉS

German Title of Invention:

NEMORUBICIN-METABOLIT UND ANALOGREAGENZIEN DAVON SOWIE ANTIKÖRPER-WIRKSTOFF-KONJUGATE DAMIT UND ENTSPRECHENDE VERFAHREN

SPC Number:

Dates

Filing date:

16/01/2009

Grant date:

15/07/2015

EP Publication Date:

15/07/2015

PCT Publication Date:

13/08/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/10/2010

EP B1 Publication Date:

15/07/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/01/2016

Expiration date:

16/01/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/01/2009

 

 

Name:

Genentech Inc.

Address:

1 DNA Way, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:

COHEN Robert L.

Address:

United States (US)

2

Name:

HA Edward Hyungsuk

Address:

United States (US)

3

Name:

REYNOLDS Mark E.

Address:

United States (US)

Priority

Priority Number:

25504

Priority Date:

01/02/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 498/14;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages